Isoray to Present at the Oppenheimer 31st Annual Healthcare Conference
Isoray, a medical technology company specializing in seed brachytherapy, announced that CEO Lori Woods will present at the Oppenheimer 31st Annual Healthcare Conference on March 17 at 11:20 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Isoray, a medical technology company specializing in seed brachytherapy, announced that CEO Lori Woods will present at the Oppenheimer 31st Annual Healthcare Conference on March 17 at 11:20 a.m. ET. She will be joined by CFO Jonathan Hunt for virtual meetings with institutional investors during the event. A live webcast of the presentation will be available on Isoray's Investor Relations website, with an on-demand replay accessible for 90 days after the event. Isoray is the sole producer of Cesium-131 brachytherapy seeds, aimed at enhancing treatment options.
Details
News Market Reaction – ISR
The recorded move for ISR in the trading session of this news was -14.18%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
RICHLAND, Wash., March 03, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE American: ISR), a medical technology company and seed brachytherapy innovator, today announced that Chief Executive Officer Lori Woods will present at the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17 at 11:20 a.m. ET. CEO Woods and Chief Financial Officer Jonathan Hunt will also host virtual one-on-one and group meetings with institutional investors during the conference.
A live webcast of the presentation will be available on Isoray’s Investor Relations section of the Company’s website at https://isoray.com/investors/presentations/. An on-demand replay of the presentation will be available shortly after the conclusion of the presentation on the Investor Relations section of the website and will be available for 90 days.
About Isoray
Isoray, Inc., through its subsidiary, Isoray Medical, Inc. is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy options throughout the body. Learn more about this innovative Richland, Washington company and explore the many benefits and uses of Cesium-131 by visiting www.isoray.com. Follow us on LinkedIn and Twitter. Join us on Facebook.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.